Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02843087 · ClinicalTrials.gov registry record
Pediatric Obesity and the Infant Microbiome (BEACH)
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 83
- Enrollment target
NCT02843087: Completed study, sponsored by University of Florida.
NCT02843087 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02843087 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
The impact of breastfeeding on the infant microbiome in vaginally and Cesarean delivered offspring from obese and normal weight mothers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2017-04-28 |
| Est. Completion | 2024-06-03 |
What the finished NCT02843087 record still lists
NCT02843087 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02843087 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02843087 about?
NCT02843087 is a clinical study titled "Pediatric Obesity and the Infant Microbiome (BEACH)". The impact of breastfeeding on the infant microbiome in vaginally and Cesarean delivered offspring from obese and normal weight mothers.
What is the current status of trial NCT02843087?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2017-04-28. Estimated completion is 2024-06-03.
Who is sponsoring clinical trial NCT02843087?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI